يعرض 1 - 10 نتائج من 23 نتيجة بحث عن '"Distrofia muscular de Becker"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    المؤلفون: Damià Vidal, Maria

    المساهمون: Pitarch Castellano, Inmaculada, Barbero Aguirre, Pedro, Meléndez Moral, Juan Carlos, Facultat de Psicologia. Programes interdepartamentals

    المصدر: RODERIC: Repositorio Institucional de la Universitat de Valéncia
    instname
    RODERIC. Repositorio Institucional de la Universitat de Valéncia

  7. 7
  8. 8

    المساهمون: Mateus Arbelaez, Heidi Eliana

    المصدر: Aartsma-rus, A., Bremmer-bout, M., Janson, A. A. M., Dunnen, J. T. Den, Ommen, G. B. Van, & Deutekom, J. C. T. Van. (2002). Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy, 12.
    Aartsma-Rus, A., Ferlini, A., & Vroom, E. (2014). Biomarkers and surrogate endpoints in Duchenne: Meeting report. Neuromuscular Disorders, 24(8), 743–745. http://doi.org/10.1016/j.nmd.2014.03.006
    Aartsma-Rus, A., Fokkema, I., Verschuuren, J., Ginjaar, I., Van Deutekom, J., Van Ommen, G. J., & Den Dunnen, J. T. (2009). Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Human Mutation, 30(3), 293–299. http://doi.org/10.1002/humu.20918
    Aartsma-rus, A., Ginjaar, I. B., & Bushby, K. (2016). The importance of genetic diagnosis for Duchenne muscular dystrophy, 1–7. http://doi.org/10.1136/jmedgenet-2015-103387
    Aartsma-Rus, A., Van Deutekom, J. C. T., Fokkema, I. F., Van Ommen, G. J. B., & Den Dunnen, J. T. (2006). Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle and Nerve, 34(2), 135–144. http://doi.org/10.1002/mus.20586
    Abbs, S., Tuffery-Giraud, S., Bakker, E., Ferlini, A., Sejersen, T., & Mueller, C. R. (2010a). Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscular Disorders : NMD, 20(6), 422–7. http://doi.org/10.1016/j.nmd.2010.04.005
    Abbs, S., Tuffery-Giraud, S., Bakker, E., Ferlini, A., Sejersen, T., & Mueller, C. R. (2010b). Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscular Disorders : NMD, 20(6), 422–7. http://doi.org/10.1016/j.nmd.2010.04.005
    Bladen, C. L., Rafferty, K., Straub, V., Monges, S., Moresco, A., Dawkins, H., … Lochmüller, H. (2013). The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Human Mutation, 34(11), 1449–57. http://doi.org/10.1002/humu.22390
    Bladen, C. L., Salgado, D., Monges, S., Foncuberta, M. E., Kekou, K., Kosma, K., … Lochmüller, H. (2015). The TREAT-NMD DMD global database: Analysis of more than 7,000 duchenne muscular dystrophy mutations. Human Mutation, 36(4), 395–402. http://doi.org/10.1002/humu.22758
    Borun, P., Kubaszewski, L., Banasiewicz, T., Walkowiak, J., Skrzypczak-Zielinska, M., Kaczmarek-Rys, M., & Plawski, A. (2014). Comparative-high resolution melting: A novel method of simultaneous screening for small mutations and copy number variations. Human Genetics, 133(5), 535–545. http://doi.org/10.1007/s00439-013-1393-1
    Brabec, P., Vondráček, P., Klimeš, D., Baumeister, S., Lochmüller, H., Pavlík, T., & Gregor, J. (2009). Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry approach. Neuromuscular Disorders, 19(4), 250–254. http://doi.org/10.1016/j.nmd.2009.01.005
    Bradley, D., & Parsons, E. (1998). Newborn screening for Duchenne muscular dystrophy. Seminars in Neonatology, 3(1), 27–34. http://doi.org/10.1016/S1084-2756(98)80146-2
    Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., … Constantin, C. (2010a). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurology, 9(1), 77–93. http://doi.org/10.1016/S1474-4422(09)70271-6
    Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., … Constantin, C. (2010b). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurology, 9(1), 77–93. http://doi.org/10.1016/S1474-4422(09)70271-6
    Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., … Constantin, C. (2010c). Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurology, 9(2), 177–89. http://doi.org/10.1016/S1474-4422(09)70272-8
    Chaustre, D. M., & Chona, W. S. (2011). Distrofia Muscular de Duchenne. Perspectivas Desde La Rehabilitación. Revista Facultad de Medicina, 19(1), 45–55.
    Ciafaloni, E., Fox, D. J., Pandya, S., Westfield, C. P., Puzhankara, S., Romitti, P. a, … Moxley, R. T. (2009). Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). The Journal of Pediatrics, 155(3), 380–5. http://doi.org/10.1016/j.jpeds.2009.02.007
    Connolly, A. M., Florence, J. M., Cradock, M. M., Malkus, E. C., Schierbecker, J. R., Siener, C. a, … Eagle, M. (2013). Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network. Neuromuscular Disorders : NMD, 23(7), 529–39. http://doi.org/10.1016/j.nmd.2013.04.005
    Cowan, D. P. (2012). Guía De Práctica Clínica. Reu-30, (Enfermedad de Paget), 1–18.
    Emery, A. E. H. & Emery, M. L. H. (1993). Edward Meryon (1809-1880) and muscular dystrophy. Journal of Medical Genetics, 30(6), 506–511. http://doi.org/10.1136/jmg.30.6.506
    En, C., & Emergencia, L. O. S. C. D. E. (n.d.). DIAGNÓSTICO Y MANEJO DE LA DISTROFIA MUSCULAR DUCHENNE, 1–36.
    Esterhuizen, A. I., Wilmshurst, J. M., Goliath, R. G., & Greenberg, L. J. (2014). Duchenne muscular dystrophy: High-resolution melting curve analysis as an affordable diagnostic mutation scanning tool in a South African cohort. South African Medical Journal, 104(11), 779. http://doi.org/10.7196/samj.8257
    Fairclough, R. J., Wood, M. J., & Davies, K. E. (2013). Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nature Reviews. Genetics, 14(6), 373–8. http://doi.org/10.1038/nrg3460
    Flanigan, K. M., Voit, T., Rosales, X. Q., Servais, L., Kraus, J. E., Wardell, C., … Wright, P. (2014). Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial. Neuromuscular Disorders, 24(1), 16–24. http://doi.org/10.1016/j.nmd.2013.09.004
    Gatheridge, M. A., Kwon, J. M., Mendell, J. M., Scheuerbrandt, G., Moat, S. J., Eyskens, F., … Griggs, R. C. (2015). Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review. JAMA Neurology, 73(1), 1–7. http://doi.org/10.1001/jamaneurol.2015.3537
    Hegde, M. R., Chin, E. L. H., Mulle, J. G., Okou, D. T., Stephen, T., & Zwick, M. E. (2009). NIH Public Access, 29(9), 1091–1099. http://doi.org/10.1002/humu.20831.Microarray-based
    Ishikawa, Y., Bach, J. R., & Minami, R. (n.d.). Cardioprotection for Duchenne ’ s muscular dystrophy, (Dcm).
    Koenig, M; Monaco, P; Kungel, L. M. (1988). The complete sequence of Dystrophin predicts a Rod-Shaped cytoskeletal protein. Cell, Vol 53.
    Kole, R., & Leppert, B. J. (2012). Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophy. Discovery Medicine. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22846203
    Li, X., Zhao, L., Zhou, S., Hu, C., Shi, Y., Shi, W., … Wang, Y. (2015). A comprehensive database of Duchenne and Becker muscular dystrophy patients (0–18 years old) in East China. Orphanet Journal of Rare Diseases, 10(1), 5. http://doi.org/10.1186/s13023-014-0220-7
    Lochm, H., Lynn, S., Roy-toole, C., Braun, S., Board, T. G., Meeting, T. O. C., … Nmds, M. (2014). CHARTER FOR THE TREAT-NMD PATIENT DATABASE / REGISTRY, (October 2007).
    Lynn, S., Aartsma-Rus, A., Bushby, K., Furlong, P., Goemans, N., De Luca, A., … Straub, V. (2015). Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders, 25(1), 96–105. http://doi.org/10.1016/j.nmd.2014.09.003
    Mah, J. K., Korngut, L., Dykeman, J., Day, L., Pringsheim, T., & Jette, N. (2014). A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscular Disorders : NMD, 24(6), 482–91. http://doi.org/10.1016/j.nmd.2014.03.008
    Ministerio de Salud y Protección Social Departamento Administrativo de Ciencia Tecnología e Innovación-Colciencias. (2015). Guía De Práctica Clínica Gpc. Guía de práctica clínica para la detección temprana, atención integral, seguimiento y rehabilitación de pacientes con diagnóstico de distrofia muscular. Retrieved from www.cenetec.salud.gob.mx
    Moizard, M. P., Billard, C., Toutain, A., Berret, F., Marmin, N., & Moraine, C. (1998). Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? American Journal of Medical Genetics, 80(1), 32–41. http://doi.org/10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y
    Muntoni, F., Torelli, S., & Ferlini, A. (2003a). Dystrophin and mutations: one gene, several proteins, multiple phenotypes. The Lancet Neurology, 2(12), 731–740. http://doi.org/10.1016/S1474-4422(03)00585-4
    Muntoni, F., Torelli, S., & Ferlini, A. (2003b). Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurology, 2(12), 731–740. http://doi.org/10.1016/S1474-4422(03)00585-4
    Na, S.-J., Kim, W.-J., Kim, S. M., Lee, K. O., Yoon, B., & Choi, Y.-C. (2013). Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 20(8), 1099–105. http://doi.org/10.1016/j.jocn.2012.09.021
    Nakabayashi, A., Sueoka, K., Tajima, H., Sato, K., Sakamoto, Y., & Katou, S. (2007). Well-devised quantification analysis for duplication mutation of Duchenne muscular dystrophy aimed at preimplantation genetic diagnosis, 233–240. http://doi.org/10.1007/s10815-007-9111-3
    Nakamura, H., Kimura, E., Mori-Yoshimura, M., Komaki, H., Matsuda, Y., Goto, K., … Kawai, M. (2013). Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy). Orphanet Journal of Rare Diseases, 8, 60. http://doi.org/10.1186/1750-1172-8-60
    Narvaja, E., & Luisa, M. (2012). Implementación de la Prueba del Multiplex PCR para el Gen DMD en Pacientes con sospecha de Distrofia Muscular de Duchenne / Becker y la identificación de una deleción de los exones 48-51 Establishment of the Multiplex PCR test for the DMD gene in patients.
    Pane, M., Fanelli, L., Mazzone, E. S., Olivieri, G., D’Amico, A., Messina, S., … Mercuri, E. (2015). Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test. Neuromuscular Disorders, 25(10), 749–753. http://doi.org/10.1016/j.nmd.2015.07.009
    Pane, M., Lombardo, M. E., Alfieri, P., D’Amico, A., Bianco, F., Vasco, G., … Mercuri, E. (2012). Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. The Journal of Pediatrics, 161(4), 705–9.e1. http://doi.org/10.1016/j.jpeds.2012.03.020
    Pane, M., Scalise, R., Berardinelli, A., D’Angelo, G., Ricotti, V., Alfieri, P., … Mercuri, E. (2013). Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscular Disorders : NMD, 23(6), 451–5. http://doi.org/10.1016/j.nmd.2013.02.012
    Pillers, D.-A. M. (2014). A new day for Duchenne’s?: The time has come for newborn screening. Molecular Genetics and Metabolism, 113(1-2), 11–3. http://doi.org/10.1016/j.ymgme.2014.06.001
    Rangel, V., Martin, A. S., & Peay, H. L. (2012, January). DuchenneConnect Registry Report. PLoS Currents. http://doi.org/10.1371/currents.RRN1309
    Rodino-klapac, L. R., & Mendell, J. R. (2013). Update on the Treatment of Duchenne Muscular Dystrophy, 1–7. http://doi.org/10.1007/s11910-012-0332-1
    Romitti, P. A., Zhu, Y., Puzhankara, S., James, K. A., Nabukera, S. K., Zamba, G. K., … Bolen, J. (2015). Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics, 135(3), 513–521. http://doi.org/10.1542/peds.2014-2044
    S.J. White, et al. (2006). Duplications in the DMD Gene. Human Mutation, 27(September), 938–945. http://doi.org/10.1002/humu
    Santos, R., Gonçalves, A., Oliveira, J., Vieira, E., Vieira, J. P., Evangelista, T., … Bronze-da-Rocha, E. (2014). New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy. Journal of Human Genetics, (February), 1–11. http://doi.org/10.1038/jhg.2014.54
    Silva, C. T., Sc, M., Fonseca, D., Restrepo, C. M., Contreras, N. C., & Mateus, H. E. (2004). Colombia Médica Colombia M é dica, 35, 191–198.
    Soltanzadeh, P., Friez, M. J., Dunn, D., von Niederhausern, A., Gurvich, O. L., Swoboda, K. J., … Flanigan, K. M. (2010). Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscular Disorders : NMD, 20(8), 499–504. http://doi.org/10.1016/j.nmd.2010.05.010
    Spurney, C. F. (2011). Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle & Nerve, 44(1), 8–19. http://doi.org/10.1002/mus.22097
    Spurney, C., Shimizu, R., Morgenroth, L. P., Kolski, H., Gordish-Dressman, H., & Clemens, P. R. (2014). Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy. Muscle and Nerve, 50(2), 250–256. http://doi.org/10.1002/mus.24163
    Takeshima, Y., Yagi, M., Okizuka, Y., Awano, H., Zhang, Z., Yamauchi, Y., … Matsuo, M. (2010). Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. Journal of Human Genetics, 55(6), 379–388. http://doi.org/10.1038/jhg.2010.69
    van Deutekom, J. C. T., & van Ommen, G.-J. B. (2003). Advances in Duchenne muscular dystrophy gene therapy. Nature Reviews. Genetics, 4(10), 774–783. http://doi.org/10.1038/nrg1180
    Wilton, S. D., Fletcher, S., & Flanigan, K. M. (2014). Dystrophin as a therapeutic biomarker: Are we ignoring data from the past? Neuromuscular Disorders, 24(6), 463–466. http://doi.org/10.1016/j.nmd.2014.03.007
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  9. 9

    المساهمون: Rosado, Pedro Simões

    المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
    Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
    instacron:RCAAP

  10. 10

    المصدر: Brazilian Journal in Health Promotion; Vol. 18 No. 1 (2005); 41-49
    Revista Brasileña en Promoción de la Salud; Vol. 18 Núm. 1 (2005); 41-49
    Revista Brasileira em Promoção da Saúde; v. 18 n. 1 (2005); 41-49
    Revista Brasileira em Promoção da Saúde
    Universidade de Fortaleza (Unifor)
    instacron:UFOR

    وصف الملف: application/pdf